[1] XIA W,LIU S,MAO Q,et al.Effect of lymph node examined count on accurate staging and survival of resected esophageal cancer[J].Thorac Cancer,2019,10(5):1149-1157.
[2] KIM SY,PARK S,PARK IK,et al.Lymph node status after neoadjuvant chemoradiation therapy for esophageal cancer according to radiation field coverage Korean[J].J Thorac Cardiovasc Surg,2019,52(5):353-359.
[3] SUGIMURA K,MIYATA H,SHINNO N,et al.Prognostic factors for esophageal squamous cell carcinoma treated with neoadjuvant docetaxel/cisplatin/5-fluorouracil followed by surgery[J].Oncology,2019,97(6):348-355.
[4] RICE TW,BLACKSRONE EH,RUSCH VW,et al.7th edition of AJCC Cancer Staging Manual:esophagus and esophagogastric junction[J].Ann Surg Oncol,2010,17(7):1721-1724.
[5] TWINE CP,LEWIS WG,MORGAN MA,et al.The assessment of prognosis of surgically resected oesphageal cancer is dependent on the number of lymph nodes examined pathologically[J].Histopathology,2009,55(1):46-52.
[6] AOYAMA J,KAWAKUBO H,MAYANAGI S,et al.Discrepancy between the clinical and final pathological findings of lymph node metastasis in superficial esophageal cancer[J].Ann Surg Oncol,2019,26(9):2874-2881.
[7] YANG M,ZHANG H,MA Z,et al.Log odds of positive lymph nodes is a novel prognostic indicator for advanced ESCC after surgical resection[J].J Thorac Dis,2017,9(5):1182-1189.
[8] AGALAR C,AYSAL A,UNEK T,et al.The role of log odds of positive lymph nodes in predicting the survival after resection for ampullary adenocarcinoma[J].Pathol Oncol Res,2020,26(1):467-473.
[9]沈文斌,许金蕊,李曙光,等.阳性淋巴结对数比对食管癌术后患者不同辅助治疗疗效的评估作用[J].中华放射医学与防护杂志,2020,40(6):454-460.
SHEN Wenbin,XU Jinrui,LI Shuguang,et al.Effect of logarithmic ratio of positive lymph nodes on the efficacy of different adiuvant treatments for patients with esophageal cancer after surgery[J].Chin J Radiol Med Prot,2020,40(6):454-460.
[10] BRAY F,FERLAY J,SOERIOMATARAM I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality world wide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424.
[11] XIA L,ZHENG R,XU Y,et al.Incidence and mortality of primary bone cancers in China,2014[J].Chin J Cancer Res,2018,30(1):1-12.
[12] ZENG H,CHEN WQ,ZHENG RS,et al.Changing cancer survival in China during 2003-15:apooled analysis of 17 population-based cancer registries[J].Lancet Glob Health,2018,6(5):e555-e567.
[13]古鹏,翟春波,胡德宏.Ⅲ期胸段食管癌术后患者的预后及其影响因素[J].实用癌症杂志,2019,34(2):245-248,253.
GU Peng,ZHAI Chunbo,HU Dehong.Prognosis of patients with stage Ⅲ thoracic esophageal cancer after operation and its infuencing factors[J].The Praclical Journal of Cancer,2019,34(2):245-248,253.
[14] LI B,XIANG J,ZHANG Y,et al.Comparison of Ivor-Lewis vs sweet esophagectomy for esophageal squamous cell carcinoma:a randomized clinical trial[J].JAMA Snrg,2015,150(4):292-298.
[15]高凯,石佳,张春敭,等.食管癌淋巴结转移危险因素分析[J].中华临床医师杂志(电子版),2018,12(11):605-608.
GAO Kai,SHI Jia,ZHANG Chuyang,et al.Risk factors for lymph node metastasis in esophageal cancer[J].Chin J Clinicians(Electronic Edition),2018,12(11):605-608.
[16] 汪亮,蔡磊,陈倩,等.pN分期、淋巴结转移率分期和阳性淋巴结对数比分期预测T3期食管鳞癌患者预后的价值[J].中华肿瘤杂志,2017,39(10):749-753.
WANG Liang,CAI Lei,CHEN Qian,et al.Prognostic value of three different staging schemes based on pN,MLR and LODDS in patients with T3 esophageal cancer[J].Chin J Oncol,2017,39(10):749-753.
[17]鲁建亮,宋昕,赵学科,等.阳性淋巴结对数比对食管鳞癌患者术后生存期的影响[J].肿瘤学杂志,2018,24(6):580-586.
LU Jianliang,SONG Xin,ZHAO Xueke,et al.Prognostic value of log odds of positive lymph nodes in patients with esophageal squamous cell carcinoma[J].Journal of Oncology,2018,24(6):580-586.
[18] WU SG,SUN JY,YANG LC,et al.Prognosis of patients with esophageal squamous cell carcinoma after esophagectomy using the log odds of positive lymph nodes[J].Oncotarget,2015,6(34):36911-36922.